Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Financial advisors offer valuable recommendations for new investors. Learn their insights to enhance your investment approach.
28,363 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Bank of America upgrades FedEx to its US 1 List, signaling confidence in the company’s DRIVE plan and a stabilizing l...
Bitcoin logged a fresh multi-week low as markets opened, but hype defies altcoin crash with notable gains in HYPE and...
Bitcoin traders are eyeing three main forces this week: fresh inflation readings, geopolitics, and evolving crypto po...
XRP enters June 2026 with mixed signals from regulators and institutions. This price prediction june 2026 outlines pl...
A private investment strategy disclosed a $100 million Bitcoin buy funded by a stock sale, boosting its BTC reserves ...
Traders weigh a potential pivot: if Bitcoin holds steady, the crypto scene may spark a 'solana summer' that could lif...
A clear look at how Vanguard Health Care and iShares Biotechnology compete for space in a diversified portfolio. Lear...
Volkswagen signals the possibility of up to 50,000 additional job cuts, potentially bringing total reductions to as m...
Booking Holdings announces a 25-to-1 stock split as investors weigh the impact on value and growth amid a year-to-dat...
Micron Technology and SanDisk shares tumbled in early trading as energy-price volatility tests cost structures at glo...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...